Stage 4 Breast Cancer - Part 3/4 - "Treatment of stage 4, HER2 positive breast cancers"

Part 3 of Stage 4 Breast Cancer for the "If I Were Your Family Member" Cancer Patient Series is directed toward patients with breast cancers that make HER2. Patients with stage 4 breast cancer that make HER2 should watch the following "If I Were Your Family Member" talks in sequence: 1) Optimizing Your ability to fight cancer 2) Stage 4 Breast Cancer Part 1 3) This talk (Stage 4 Breast Cancer Part 3) of the "If I Were Your Family Member" Cancer Patient Series. Dr. Basem Goueli MD, Ph.D., MBA does things you have never seen as he discusses: 1) Understanding the protein expression profile of your cancer (Estrogen Receptor, Progesterone Receptor, HER2) 2) Overview of proteins that inhibit HER2 3) Reason for hope 4) Molecular profiling overview 5) Clinical trials 6) Playing chess against cancer 7) Determining the bullets in the gun to fight your cancer 8) Discussion of bullet 1 (first-line treatment) 9) Discussion of bullet 2 (second-line treatment) 10) Discussion of bullet 3 (third-line treatment) 11) Discussion of bullet 4 (fourth-line treatment onward) 14) Brain metastases in breast cancer and the use of radiation, surgery (rare), and drugs that cross the blood brain barrier This talk includes a discussion of the risk (side effects) and benefit of chemotherapies, including taxol, taxotere, and xeloda. It includes a similar discussion of HER2 targeting treatments, including herceptin, perjecta, kadcyla, neratinib, tucatinib, tykerb, and margenza. Endocrine therapies, including arimidex, exemestane, femara, faslodex, and tamoxifen are also discussed. This episode builds off of episode 1 of this series and should be viewed in the sequence above. Episode 4 of Stage 4 Breast Cancer will focus on triple-negative patients and will take place on August 20, 2022.